Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.46 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.46 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21295572 | 0.89 | HTT (0.44) | FFAR1 | |
| SCHEMBL2401504 | 0.88 | HTT (0.43) | FFAR1 | |
| SCHEMBL26925526 | 0.83 | SPHK1 (0.40) | FFAR1 | |
| SCHEMBL9816488 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CNR1CNR2LPAR2LPAR3 | |
| SCHEMBL5415132 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CNR1CNR2LPAR2LPAR3 | |
| SCHEMBL15817629 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CNR1CNR2LPAR2LPAR3 | |
| SCHEMBL5415141 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CNR1CNR2LPAR2LPAR3 | |
| SCHEMBL1053426 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CNR1CNR2LPAR2LPAR3 | |
| SCHEMBL482608 | 0.83 | ALDH1A1 (0.54) | ALDH1A1CNR1CNR2LPAR2LPAR3 | |
| SCHEMBL34463880 | 0.79 | ALDH1A1 (0.53) | ALDH1A1CNR1CNR2LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7744858-B2 | Stable composition with high electrolyte content containing an amphiphilic polymer | L'OREAL (FR) | 2010-06-29 | — | — | US | disclosed |
| US-20030108577-A1 | Cosmetic and/or dermatological acid composition containing an amphiphilic polymer | L'OREAL (FR) | 2003-06-12 | — | — | US | disclosed |
| US-20030036490-A1 | Stable composition with high electrolyte content containing an amphiphilic polymer | L'OREAL (FR) | 2003-02-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030108577-A1 | Cosmetic and/or dermatological acid composition containing an amphiphilic polymer | KRT18, DSG1, CUTA | ALDH1A1 1813/4885CNR1 2702/4885CNR2 2470/4885 |
| US-20030036490-A1 | Stable composition with high electrolyte content containing an amphiphilic polymer | KRT18, DSG1, SCNN1A | ALDH1A1 3241/4885CNR1 4041/4885CNR2 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.